【ALS】《NeuroSense: NRSN》宣布與《PhaseV》合作PrimeC 治療「ALS」3期臨床

 【ALS】神經退化《NeuroSense: NRSN》宣布與《PhaseV》合作PrimeC 治療「肌萎縮性側索硬化症(ALS)」3期臨床

 文章出處  

Biospace 

 

 原文標題  

NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning 

 

 Twitter  

https://twitter.com/aimedadviser/status/1791256559907119224 

 

 文章序號  

5592 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.